How to treat endometrial polypoid hyperplasia

The uterus is a relatively important reproductive organ in women and is also an area that is prone to lesions. Therefore, we must pay special attention to possible abnormalities in the uterus. Some women are very worried about the occurrence of endometrial polypoid hyperplasia. In fact, endometrial polypoid hyperplasia is endometrial hyperplasia, which has a certain tendency to become cancerous and must be treated in a timely manner. How to treat endometrial polypoid hyperplasia?

For the treatment of atypical endometrial hyperplasia, we must first make a clear diagnosis and find out the cause. If it is accompanied by polycystic ovary, functional ovarian tumors, or other endocrine dysfunction, targeted treatment should be performed. At the same time, symptomatic treatment should be started immediately for those diagnosed with atypical endometrial hyperplasia, using medication or surgical treatment. The choice of plan should be determined based on the patient's age, fertility requirements, and physical health condition. For those under 40 years old, their tendency to cancer is low and drug treatment can be considered first. Young people who hope to have children should try drug treatment first, because after drug treatment, about 30% of patients may still become pregnant and give birth to a full-term baby. For women before and after menopause, the potential for cancer is higher than that of younger people, so hysterectomy is often performed directly.

1. The principle of drug treatment is

Standardized medication, long-term examinations, regular testing, and timely assisted pregnancy. Types of medication: ① The ovulation-inducing drug clomiphene is taken once a day on the 5th to 9th day of the cycle. If necessary, the medication period can be extended by 2 to 3 days. ② Progestin drugs: They vary according to the degree of endometrial atypicality. Mild atypical hyperplasia can be treated with intramuscular injection of progesterone, starting on the 18th or 20th day of the cycle, and taken for 5-7 days. Patients with moderate and severe atypical hyperplasia should use medroxyprogesterone continuously for a course of 3 months. After each course of treatment, a curettage or removal of endometrial tissue should be performed for histological examination. Depending on the response to the drug, the patient can choose to stop treatment or increase or decrease the dosage of the drug as appropriate. An intrauterine ring can also be placed.

2. Surgery

Curettage and aspiration is not only an important diagnostic method, but also one of the treatment methods. Because local lesions can also be removed through curettage. Patients with atypical endometrial hyperplasia who are over 40 years old and have no fertility requirements can undergo hysterectomy once diagnosed. However, for patients with hypertension, diabetes, obesity or advanced age who have poor tolerance to surgery, drug treatment may be considered under close follow-up monitoring. Young patients who have not responded to drug treatment, whose endometrial hyperplasia continues or worsens or is suspected of having developed cancer, whose vaginal bleeding cannot be controlled by curettage and drug treatment, and whose condition recurs after delivery, may all consider surgical removal of the hysterectomy.

The above is an introduction to the treatment of endometrial polypoid hyperplasia. I hope it will be helpful to patients. Although gynecological diseases that generally occur in the female uterus are not very harmful, they can be cured as long as they are treated actively. However, endometrial polypoid hyperplasia has a tendency to become cancerous, so it must be treated in time to avoid more serious consequences.